F&D
Overview
Formulation development is the core art and science of preparation of the dosage form. All pharmaceutical products are formulated to specific dosage forms for drugs to be effectively delivered to patients. Typical pharmaceutical dosage forms include parenteral and nonparenteral dosage forms. A variety of dosage forms require separate pharmaceutical technologies to be adopted and usually present different technical challenges for formulation development.
Area of Interest
Novel Drug Delivery systems
- Nanoparticles (Polymeric, solid lipid, liposomes)
- Micelles
- Colloidal carriers
- Polymer-drug conjugates
- Ligand appending/Targeting (Targeted drug delivery systems)
Recently Published Work
Pharmacodynamic Assessment of VRT001-C (Oral Ceftriaxone) vs. IV Ceftriaxone Against Escherichia coli in the Neutropenic Murine Thigh Infection Model
presented at the 29th ECCMID, the European Congress of Clinical Microbiology and Infectious Diseases, which took place in Amsterdam, Netherlands, 13 – 16 April 2019.
Ganguly K, Payasi A, Roy D, Sachdeva A, Chaudhary M, Chaudhary S, Aggarwal A. Poster number L0029
Polymeric micelles: Basic research to clinical practice. International Journal of Pharmaceutics
532(1),2017, 249-268 Impact factor 3.649
Anand S Deshmukh, Pratik N Chauhan, Malleshappa N Noolvi, Kiran Chaturvedi, Kuntal Ganguly, Shyam S Shukla, Mallikarjuna N Nadagouda, Tejraj M Aminabhavi
Oral insulin delivery using deoxycholic acid conjugated PEGylated polyhydroxybutyrate co-polymeric nanoparticles
2015. Nanomedicine 10 (10), 1569-1583 Impact factor 5.82
D Kumar, K Ganguly, HV Hegde, PA Patil, AK Sharma, RK Joshi, S Roy, SD Kholkute
Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review
Expert Opinion on Drug Delivery, Volume 8, Number 11, November 2011, pp. 1455-1468(14). Impact factor 4.896, citations 10
Chaturvedi Kiran, Ganguly Kuntal, Kulkarni Anandrao R, Kulkarni Venkatarao H, Nadagouda Mallikarjuna N, Rudzinski Walter E, Aminabhavi Tejraj M
Discover our areas of work
STN
With an aim to preserve the life of existing antibiotics and to guide better clinical decisions
SPIPC
Venus has developed a super porous interpolymeric complex based on physical charge
DPPC
Venus team is working on target-based drug delivery for cancer treatment. The Company has designed a platform
